S&P Global Ratings is considering whether to reclassify Centene Corp.'s credit ratings to junk, which would strongly impact its borrowing power. Centene, the top seller of ACA health plans, is ...

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

President Trump and Republicans’ tax law is one of the most significant pieces of health care legislation since the ACA. It ...

Centene's stock plunges 40% with EPS slashed by 50%. Discover why valuation may seem cheap but key challenges make CNC stock a cautious investment.

The U.S. House of Representatives passed President Donald Trump’s tax-cut and spending bill on Thursday, which contains ...

The U.S. House of Representatives passed President Donald Trump's tax-cut and spending bill on Thursday, which contains ...

Centene's prospects are bolstered by demographic trends, Medicaid privatization, and ACA Marketplace demand, with expected improvements in cash flow and profitability.

Centene sets itself up for ‘equilibrium’ in 2025 The insurer also reported notable ACA growth for this year, though membership could tick back down through the second quarter due to program ...

Some of the remarks could be mistaken for political ads that might run if Republicans pursue Medicaid cuts or don’t extend ACA subsidies.

One tailwind Centene called out driving ACA growth is ICHRA, or Individual Coverage Health Reimbursement Arrangements. The model first became available in 2020 as an alternative to traditional ...

Centene is swapping CVS Caremark with Express Scripts. A recent survey that measured benefit leaders' satisfaction with their PBMs found that Express Scripts performed better than CVS Caremark.